Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPRED2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EFCAB14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUSP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFT2D3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HIVEP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP3A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC11A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCUN1D3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MT1E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNOT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGFA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TECPR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZSCAN29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRWD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARID1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927668 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAGS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on